Stockscreener 앱 받기
3.41
4.28%
0.14
전일 마감가:
$3.27
열려 있는:
$3.24
하루 거래량:
557.45K
Relative Volume:
1.23
시가총액:
$77.28M
수익:
$52.55M
순이익/손실:
$-23.69M
주가수익비율:
-3.6277
EPS:
-0.94
순현금흐름:
$-15.29M
1주 성능:
+3.96%
1개월 성능:
-28.06%
6개월 성능:
-65.35%
1년 성능:
-9.79%
1일 변동 폭
$3.17
$3.4288
1주일 범위
$3.15
$3.4288
52주 변동 폭
$2.77
$12.23
Exagen Inc Stock (XGN) Company Profile
명칭
Exagen Inc
전화
(760) 560-1501
주소
1261 LIBERTY WAY, VISTA, CA
Compare XGN vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
3.41 | 74.11M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
510.93 | 193.53B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
209.50 | 149.33B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
635.66 | 50.36B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
122.90 | 35.73B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
333.33 | 32.24B | 3.17B | 642.63M | 539.81M | 10.77 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-11 | 개시 | B. Riley Securities | Buy |
| 2025-07-30 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | 개시 | Craig Hallum | Buy |
| 2022-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-04-15 | 개시 | Canaccord Genuity | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-06-02 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-14 | 개시 | Cowen | Outperform |
| 2019-10-14 | 개시 | William Blair | Outperform |
모두보기
Exagen Inc 주식(XGN)의 최신 뉴스
What are Exagen Inc.’s recent SEC filings showingJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - mfd.ru
RTW INVESTMENTS, LP Reduces Stake in Exagen Inc: A Strategic Por - GuruFocus
How interest rate cuts could boost Exagen Inc. stockWeekly Investment Summary & Daily Momentum Trading Reports - mfd.ru
Exagen (NASDAQ:XGN) Price Target Lowered to $10.00 at BTIG Research - MarketBeat
Exagen (XGN) Analyst Lowers Price Target, Maintains Buy Rating | - GuruFocus
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Returns Recap: Can Exagen Inc maintain sales growthWeekly Investment Recap & Low Risk Profit Maximizing Plans - baoquankhu1.vn
What Analysts Think Is Changing The Story For Exagen (XGN) Now - Yahoo Finance
Exagen Inc. (NASDAQ:XGN) Short Interest Down 67.3% in January - MarketBeat
Aug EndMonth: Is NVMI exposed to political risk2025 Price Momentum & Daily Stock Trend Watchlist - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Trend Recap: Is Exagen Inc being accumulated by smart moneyWeekly Trade Recap & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Performance Recap: Is HBANM a speculative investmentRecession Risk & Technical Pattern Based Buy Signals - baoquankhu1.vn
Bearish Setup: What are ICCTs earnings expectationsWeekly Trade Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
B. Riley Reaffirms Buy Rating for Exagen (NASDAQ:XGN) - Defense World
Short Interest in Exagen Inc. (NASDAQ:XGN) Expands By 65.7% - MarketBeat
B. Riley Cuts Price Target on Exagen to $8 From $18, Keeps Buy Rating - marketscreener.com
XGN: B. Riley Securities Lowers Price Target, Maintains Buy Rati - GuruFocus
Exagen's (XGN) "Buy" Rating Reaffirmed at B. Riley - MarketBeat
Is Exagen Inc. impacted by rising rates2025 Volume Leaders & High Accuracy Investment Signals - mfd.ru
How The Exagen (XGN) Story Is Shifting With A New Analyst Price Target - Yahoo Finance
Volume Recap: Does Crescent Capital BDC Inc stock reflect fundamentals2025 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn
Benign Growth For Exagen Inc. (NASDAQ:XGN) Underpins Stock's 26% Plummet - 富途牛牛
Trend Report: Will Exagen Inc benefit from current market trendsTrade Entry Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Sees Large Growth in Short Interest - MarketBeat
Investors Don't See Light At End Of Exagen Inc.'s (NASDAQ:XGN) Tunnel And Push Stock Down 28% - Sahm
Selling Exagen Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Sahm
Tech Rally: Is Exagen Inc. benefiting from innovation trends2025 Trading Volume Trends & Breakout Confirmation Alerts - baoquankhu1.vn
Exagen Inc. (NASDAQ:XGN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
ETF Watch: How Exagen Inc stock benefits from global expansionJuly 2025 Technicals & Community Consensus Stock Picks - Bộ Nội Vụ
Published on: 2026-01-13 10:11:31 - ulpravda.ru
Analysts Are Bullish on These Healthcare Stocks: Exagen (XGN), Medline, Inc. Class A (MDLN) - The Globe and Mail
How Recent Analyst Resets Are Reframing The Exagen (XGN) Investment Story - Yahoo Finance
Exagen Announces Record 2025 Revenue and Strong Cash Position - TipRanks
Canaccord Genuity maintains Buy rating on Exagen stock amid ASP challenges - Investing.com Canada
California-based Exagen preliminary revenue up 19% in FY25 - Medical Buyer
Exagen (XGN) Reports Strong Annual Growth and Strategic Advances - GuruFocus
Exagen Inc. Reports Preliminary Financial Results for Q4 and Full Year 2025, Highlighting Record Revenue Growth - Quiver Quantitative
Exagen Inc. Announces Select Preliminary 2025 Financial Results - Bluefield Daily Telegraph
Autoimmune testing firm Exagen ends 2025 with record sales and more cash - Stock Titan
Why Exagen Inc. stock could rally in 2025Forecast Cut & Real-Time Sentiment Analysis - Улправда
T Inc Class stock compares with tech leaders2025 Top Gainers & Safe Capital Allocation Plans - ulpravda.ru
Aug Macro: What margin trends mean for Exagen Inc. stockMarket Growth Review & Long-Term Safe Return Strategies - ulpravda.ru
Is Exagen Inc. stock positioned well for digital economyMarket Trend Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
What margin trends mean for Exagen Inc. stockEarnings Growth Summary & Weekly Market Pulse Alerts - ulpravda.ru
What makes Exagen Inc. stock attractive to growth funds2025 Market Overview & Stock Portfolio Risk Management - ulpravda.ru
Revenue Check: Can Huron Consulting Group Inc. stock deliver surprise earnings beat2025 Macro Impact & AI Forecast Swing Trade Picks - ulpravda.ru
2026 world cup usa squad group stage veteran players set piece strategy knockout prediction analysis - ulpravda.ru
ulpravda ru > 2026> Will LIMN stock beat EPS estimatesQuarterly Trade Summary & High Conviction Buy Zone Picks - ulpravda.ru
Will Exagen Inc. stock outperform Dow Jones indexJuly 2025 Catalysts & Long-Term Safe Return Strategies - Улправда
Will Exagen Inc. (E08A) stock split increase liquidityEarnings Risk Report & Stepwise Trade Signal Implementation - ulpravda.ru
Exagen Inc (XGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.01%
0.07%
자본화:
|
볼륨(24시간):